Information;Judgment — ECLI:EU:T:2022:101
Date: 2022-03-02
Language of the case: English
Court formation: Second Chamber
Subject matter: Trade marks;Intellectual, industrial and commercial property
Procedure: Action for annulment - unfounded
Origin: Germany

Action brought on 4 December 2020 – Degode v EUIPO – Leo Pharma (Skinovea) (Case T-715/20) Language of the case: English Parties Applicant: DEGODE - Dermago Development GmbH (Petershagen, Germany) (represented by: O. Spieker, A. Schönfleisch and N. Willich, lawyers) Defendant: European Union Intellectual Property Office (EUIPO) Other party to the proceedings before the Board of Appeal: Leo Pharma A/S (Ballerup, Denmark) Details of the proceedings before EUIPO Applicant of the trade mark at issue: Applicant before the General Court Trade mark at issue: Application for European Union word mark Skinovea – Application for registration No 17 898 565 Procedure before EUIPO: Opposition proceedings Contested decision: Decision of the Fifth Board of Appeal of EUIPO of 4 September 2020 in Case R 337/2020-5 Form of order sought The applicant claims that the Court should: annul the contested decision; order the defendant to bear the costs of the proceedings. Plea in law Infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council. ____________